Bioxyne Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of BXN?
Owner Type	Number of Shares	Ownership Percentage
General Public	458,158,121	22.4%
Private Companies	532,278,223	26%
Individual Insiders	1,058,792,388	51.7%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 7.8%.

Top Shareholders

Top 21 shareholders own 77.64% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
31%	Samuel Watson	635,000,746	AU$16.5m	-5.47%	no data
8.56%	Global CR Holdings Limited	175,450,850	AU$4.6m	17%	no data
7.7%	Kirkman Trading Ltd	157,805,604	AU$4.1m	90.6%	no data
6.47%	Ian Owles	132,488,966	AU$3.4m	0%	no data
3.88%	Bpmgmt Ltd	79,493,379	AU$2.1m	0%	no data
3.1%	Nam Chua	63,574,013	AU$1.7m	-44.8%	no data
1.76%	Paramount Star Investments Limited	36,000,000	AU$936.0k	0%	no data
1.7%	Gavin Ogilvie	34,778,354	AU$904.2k	0%	no data
1.7%	Andrew Ogilvie	34,778,354	AU$904.2k	0%	no data
1.7%	Paula Ogilvie	34,778,354	AU$904.2k	0%	no data
1.7%	Terrence Stephens Pty Ltd	34,778,354	AU$904.2k	0%	no data
1.46%	Grace Investments - Fzco	30,000,000	AU$780.0k	0%	no data
1.41%	Anthony Ho	28,803,567	AU$748.9k	73.4%	no data
1.12%	Kee-Siong Chia	23,050,000	AU$599.3k	0%	no data
0.98%	Chun-Chieh Hsu	20,000,000	AU$520.0k	0%	no data
0.91%	Taos Pty Ltd	18,750,036	AU$487.5k	0%	no data
0.83%	Simon Panton	17,021,550	AU$442.6k	0%	no data
0.55%	Makram Hanna	11,294,297	AU$293.7k	0%	no data
0.55%	Rita Hanna	11,294,297	AU$293.7k	0%	no data
0.52%	Guy Robertson	10,605,000	AU$275.7k	0%	no data
0.065%	Jason Hine	1,324,890	AU$34.4k	0%	no data

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/25 20:37
End of Day Share Price	2024/12/24 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Bioxyne Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution